- BX002 demonstrated safety and tolerability with successful delivery of a high concentration of viable phage to the lower...

Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with...

JERUSALEM (Reuters) - Israel’s Biond Biologics Ltd said on Tuesday it had forged an exclusive global licence agreement, potentially worth...

9 December 2020 – Alstom has finalised a deal to invest US$7 million in Cylus, an Israel-based cybersecurity specialist, thus acquiring a...

Trigo, a global leader in frictionless checkout technology, has raised a $60 million Series B funding round led by 83North. The latest...